Insider Monkey - 2025-08-20 04:22
Compass Therapeutics, Inc. (NASDAQ:CMPX) is one of the top multibagger penny stocks to buy, according to analysts. On August 11, Raymond James reiterated its ‘Outperform’ rating with a $9 price target following the company’s second-quarter financial results. The company reported a net loss of $19.9 million, or $0.14 per share, compared to a net loss […]